Search

The treatment of low back pain usually includes exercise, analgesics, prostheses, and, in severe cases, surgery. Early treatments based on postural control are essential to prevent low back pain and mitigate permanent damage. This paper presents a wearable device with an estimated cost below $100 that uses inertial units with triaxial accelerometers, gyroscopes, and magnetometers to measure the orientation of three sections of the spine. The device integrates the absolute and relative orientations from the sensors to estimate the posture of the back in real-time and uses a fuzzy system to control a vibration unit that indicates to the user when to correct the posture of the back. This paper validated the device in controlled conditions, obtaining an rms deviation ≤1.24, and conducted a preliminary clinical pilot study with patients afflicted by lumbar hyperlordosis. This paper observed improved postural control and a reduction of low back pain in all cases. These results show the device's promising potential to reduce pain, improve postural therapies, and raise postural awareness in patients with low back pain. [ABSTRACT FROM AUTHOR]

Genetic conditions affecting eyesight can lead to vision loss due to a variety of disorders. These include traumatic events such as car accidents or blast injuries, as well as diseases like retinitis pigmentosa, glaucoma, and macular degeneration. After an accident or explosion, the remaining portion of the eye's nerve pathway may still function, allowing electrical devices to transmit significant images to the brain through a network of electrodes. Although current devices offer relatively limited vision, there has been significant progress since the initial proof of concept. Three devices have been approved for general use in various regions around the world, and several more are currently undergoing approval. The prospects for widespread adoption of device-based treatments for vision loss are promising. Much of the recent progress is due to advancements in semiconductors and biological compatibility. To create artificial vision and restore functionality, a camera or other image source electrically stimulates the residual healthy cells or tissues. [ABSTRACT FROM AUTHOR]

Infection is a serious risk in transplant surgery and should be carefully considered while developing biomaterials. Silver nanoparticles (AgNPs) are gaining popularity due to their ability to enhance antibacterial capabilities against a wide range of bacterial types. This study sought to create two antibacterial bone regenerations by incorporating AgNPs into bovine bone particles (BBX) (Product 1) and a light cross-linked hydrogel GelMA (Product 2). Scanning electron microscopy was used to characterize the constructions. PrestoBlue™ was used to assess osteoblast and osteoclast metabolic activities on the creations. Optimized AgNP functionalized BBX and GelMA were tested in a rabbit cranial 6mm defect model to assess their regeneration ability. The presence of AgNPs appears to increase. In vitro, osteoblasts proliferated more than AgNP-free controls. It is found that a 100 jg dosage of AgNPs effectively suppresses bacteria while minimizing negative effects on bone cells. The rabbit model indicated that both BBX and GelMA hydrogels loaded with AgNPs were biocompatible, with no evidence of necrosis or inflammation. Grafts functionalized with AgNPs can defend against germs while also serving as a platform for bone cell adhesion. [ABSTRACT FROM AUTHOR]

This paper discusses the current challenges and potential solutions in the field of bioprinting tissues and organs. It highlights that most bioprinted tissues are small, composed of few cell types, lack vascular systems, and have limited functionality. This paper emphasizes the need to develop methods to obtain various functional cell types, create vascular systems for nutrient delivery, and enhance the size and capabilities of 3D-printed tissue structures. Additionally, it explores the advancements in nanorobots in the medical field, focusing on their unique properties and applications in various medical areas like cancer, cardiology, and neurology. [ABSTRACT FROM AUTHOR]

Artificial Intelligence (AI) is a cutting-edge technology that analyzes complex data using computer algorithms. Diagnostic imaging is one of the most potential clinical uses of AI, and increasing effort is being put toward optimizing its functionality to make a wide range of clinical problems easier to identify and quantify. Research employing computeraided diagnostics has demonstrated exceptional precision, sensitivity, and specificity in identifying minute radiographic irregularities, which has promise for enhancing public health. However, lesion identification is often used to define result assessment in AI imaging research, neglecting the nature and biological aggressiveness of a lesion. This might lead to a distorted portrayal of AI's performance. Some AI imaging research evaluate clinically significant results, whereas others compute sensitivity and specificity to quantify diagnostic accuracy. Though AI frequently picks up on little changes to images, more significant outcome factors include newly discovered advanced disease, illnesses that need to be treated, or circumstances that might have an impact on long-term survival. AI-based research should concentrate on clinically significant events since they have a significant impact on quality of life, such as symptoms, the requirement for disease-modifying medication, and death. Numerous research have demonstrated that AI outperforms normal reading in terms of specificity and recall rates; nevertheless, the kind and biological aggressiveness of a lesion are often overlooked in the estimation of accuracy and sensitivity. [ABSTRACT FROM AUTHOR]

Medical imaging methods such as optical imaging have advanced significantly in their ability to diagnose and monitor various illnesses without any invasive procedures. Optical imaging offers a detailed view of anatomical structures and molecular processes, utilizing the unique properties of light and its interactions with biological tissues. This paper provides a comprehensive overview of optical imaging principles, including techniques like Optical Coherence Tomography (OCT), fluorescence imaging, and diffuse optical imaging. Optical imaging methods provide non-invasive, detailed views of biological tissues, enabling early disease detection and monitoring, thereby significantly advancing diagnostic capabilities and improving patient outcomes. These methods are used in the detection of diseases such as cancer, cardiovascular conditions, and neurological disorders. [ABSTRACT FROM AUTHOR]

Bladder cancer treatment with intravenous medication delivery has reasonable survival rates but modest therapeutic efficacy. Taking advantage of their superior diffusion and mixing capacities in urine compared to traditional pharmaceuticals or passive nanoparticles, self-propelled nanoparticles, also known as nanobots, have been proposed as a solution to the latter issue. Nonetheless, nothing is known about how well nanobots can translate into bladder cancer treatments. Here, urease-powered, radiolabelled mesoporous silica-based nanobots were evaluated in an orthotopic animal model of bladder cancer. Both in vivo and ex vivo findings showed increased accumulation of nanobots at the tumor location; positron emission tomography in vivo showed an eight-fold increase. The ex vivo tumor penetration by nanobots was validated by label-free optical contrast based on polarization-dependent scattered light-sheet microscopy of cleared bladders. Intravesically treatment was given to tumor-bearing mice. About 90% less tumor size was observed when radio-iodinated nanobots were used for radionuclide therapy, establishing nanobots as effective delivery nanosystems for bladder cancer treatment. [ABSTRACT FROM AUTHOR]

The realm of 3D printing is rapidly evolving, offering a wide range of options from typical thermoplastics to advanced graphene-based composites. This technology improves production efficiency and gives consumers more control over customizing products and specifications. However, alongside its transformative potential, 3D printing also presents challenges, such as potential impacts on manufacturing jobs and security issues. Since its modest beginnings in developing visualization models, 3D printing has evolved to transform the manufacturing of distinct devices, implants, tissue engineering scaffolds, and drug delivery systems. This paper explores the most recent progress in 3D printing materials, including smart materials, ceramics, electronics, biomaterials, and composites, emphasizing the significance of adapting to changing materials and product requirements. It delves into the complex connection between printing parameters and the characteristics of printed composite parts, providing new opportunities to improve the strength and functionality of 3D-printed components. This review highlights how 3D printing can be utilized in various industries, such as medical devices and explosives research, using materials such as titanium, aluminum, carbon fiber, and thermoplastic polyurethanes. With the continuous growth of the 3D printing field, it is essential to adopt new methods and materials to fully realize its impact on the future of manufacturing and product development. [ABSTRACT FROM AUTHOR]

Bioprinting has been a trending technology in recent years. It is a combination of engineering and biology. It can be used in the fields of tissue engineering and drug screening. It can be used to print 3D structures using 3D modeling software and to print with cultured cells. Bioink should have cells with the following characteristics: cell viability, cell differentiation, degradation, biocompatibility, and printability. Bioink contains biomaterials, living cells, and growth factors that are used to grow the cells. The replaced cells should possess chemical, physical, and mechanical properties. There are several methods to print biological organs, including microextrusion, inkjet bioprinting, and stereolithography. [ABSTRACT FROM AUTHOR]

There are several classifications that describe the way materials function in the body. Devices that mimic a portion or function of the body in a safe, dependable, cost-effective, and physiologically appropriate way are made using biomaterials. Numerous tools and substances are now employed in the treatment of illness or injury, including everyday objects like tooth fillings, sutures, needles, catheters, plates, and so on. As time goes on, a synthetic substance that functions in close contact with live tissue or replaces a portion of a biological system might be summed up as a biomaterial. A biomaterial is described as "a systemically and pharmacologically inert substance designed for implantation within or incorporation with living things" by the Clemson University Advisory Board for Biomaterials. Materials, whether synthetic or natural, that may be utilized in any system that treats, enhances, or substitutes any organ, tissue, or bodily function for any length of time or on the other hand, a biological substance is one that is created by a biological system, like skin or an artery. [ABSTRACT FROM AUTHOR]